• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于美国癌症联合委员会(AJCC)分期和组织学分级的手术切除后胰腺神经内分泌肿瘤列线图的建立与验证

Establishment and validation of an AJCC stage- and histologic grade-based nomogram for pancreatic neuroendocrine tumors after surgical resection.

作者信息

Zhang Chuanzhao, Wu Yanxia, Zhuang Hongkai, Li Dezhi, Lin Ye, Yin Zi, Lu Xin, Hou Baohua, Jian Zhixiang

机构信息

Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, People's Republic of China.

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510080, People's Republic of China.

出版信息

Cancer Manag Res. 2019 Aug 5;11:7345-7352. doi: 10.2147/CMAR.S200340. eCollection 2019.

DOI:10.2147/CMAR.S200340
PMID:31496796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6689125/
Abstract

BACKGROUND

Development of an accurate model to predict prognosis for patients with pancreatic neuroendocrine tumors (P-NETs) after surgical resection is urgently needed.

METHODS

In the present study, we conducted Cox proportional hazards regression to identify critical prognostic factors for P-NETs by analyzing data from 2174 patients in the Surveillance, Epidemiology, and End Results (SEER) database. Based on the results of multivariate analysis, a novel nomogram was established. Finally, the novel nomogram for P-NETs was validated in a cohort of 81 patients from a Chinese institute.

RESULTS

In the multivariate analysis, age, tumor location, American Joint Committee on Cancer (AJCC) stage, histologic grade, lymph node ratio (LNR) and tumor size were independent risk factors for overall survival (OS) in P-NET patients who underwent radical resection. A nomogram consisting of age, sex, AJCC stage and histologic grade was found to have a concordance index (C-index) of 0.79 for OS in the SEER database, which was significantly higher than the C-index based on the AJCC stage, European Neuroendocrine Tumor Society (ENETS) stage or histologic grade alone. In the validation cohort, the C-index based on the nomogram reached 0.78 for OS. We also defined high-risk (total points >13.5 based on the nomogram) and low-risk populations (total points <13.5 based on the nomogram) in the validation cohort. We found that the actual 5-year recurrence rate in the high-risk group was significantly higher than that in the low-risk group (80.8% vs 23.4%, <0.001). Kaplan-Meier analysis showed that the 5-year recurrence-free survival (RFS) in the low-risk group was significantly higher than that in the high-risk group (<0.001).

CONCLUSION

An AJCC stage- and histologic grade-based model was found to be extremely efficient in predicting survival for patients with P-NETs after surgical resection and deserves further evaluation for future clinical applications.

摘要

背景

迫切需要开发一种准确的模型来预测胰腺神经内分泌肿瘤(P-NETs)患者手术切除后的预后。

方法

在本研究中,我们通过分析监测、流行病学和最终结果(SEER)数据库中2174例患者的数据,进行Cox比例风险回归以确定P-NETs的关键预后因素。基于多变量分析结果,建立了一种新型列线图。最后,在一家中国机构的81例患者队列中对新型P-NETs列线图进行了验证。

结果

在多变量分析中,年龄、肿瘤位置、美国癌症联合委员会(AJCC)分期、组织学分级、淋巴结比率(LNR)和肿瘤大小是接受根治性切除的P-NET患者总生存(OS)的独立危险因素。发现由年龄、性别、AJCC分期和组织学分级组成的列线图在SEER数据库中OS的一致性指数(C指数)为0.79,显著高于仅基于AJCC分期、欧洲神经内分泌肿瘤学会(ENETS)分期或组织学分级的C指数。在验证队列中,基于列线图的OS的C指数达到0.78。我们还在验证队列中定义了高危人群(基于列线图总分>13.5)和低危人群(基于列线图总分<13.5)。我们发现高危组的实际5年复发率显著高于低危组(80.8%对23.4%,<0.001)。Kaplan-Meier分析显示低危组的5年无复发生存(RFS)显著高于高危组(<0.001)。

结论

发现基于AJCC分期和组织学分级的模型在预测P-NET患者手术切除后的生存方面极其有效,值得在未来临床应用中进一步评估。

相似文献

1
Establishment and validation of an AJCC stage- and histologic grade-based nomogram for pancreatic neuroendocrine tumors after surgical resection.基于美国癌症联合委员会(AJCC)分期和组织学分级的手术切除后胰腺神经内分泌肿瘤列线图的建立与验证
Cancer Manag Res. 2019 Aug 5;11:7345-7352. doi: 10.2147/CMAR.S200340. eCollection 2019.
2
Comparison of prognostic prediction between nomogram based on lymph node ratio and AJCC 8th staging system for patients with resected pancreatic head carcinoma: a SEER analysis.基于淋巴结比率的列线图与美国癌症联合委员会第八版分期系统对切除的胰头癌患者预后预测的比较:一项监测、流行病学和最终结果分析
Cancer Manag Res. 2018 Feb 5;10:227-238. doi: 10.2147/CMAR.S157940. eCollection 2018.
3
A Novel Nomogram including AJCC Stages Could Better Predict Survival for NSCLC Patients Who Underwent Surgery: A Large Population-Based Study.一项包含美国癌症联合委员会(AJCC)分期的新型列线图能更好地预测接受手术的非小细胞肺癌患者的生存情况:一项基于大样本人群的研究。
J Oncol. 2020 May 20;2020:7863984. doi: 10.1155/2020/7863984. eCollection 2020.
4
Lymph node ratio and hematological parameters predict relapse-free survival in patients with high grade rectal neuroendocrine neoplasms after radical resection: a multicenter prognostic study.淋巴结比率和血液学参数可预测根治性切除术后高级直肠神经内分泌肿瘤患者的无复发生存:一项多中心预后研究。
World J Surg Oncol. 2023 Sep 22;21(1):300. doi: 10.1186/s12957-023-03144-0.
5
A Nomogram Based on the Log Odds of Positive Lymph Nodes Predicts the Prognosis of Patients With Distal Cholangiocarcinoma After Surgery.基于阳性淋巴结对数比值的列线图预测远端胆管癌患者术后预后
Front Surg. 2021 Oct 26;8:757552. doi: 10.3389/fsurg.2021.757552. eCollection 2021.
6
Nomogram for the prediction of lymph node metastasis and survival outcomes in rectal neuroendocrine tumour patients undergoing resection.用于预测接受切除术的直肠神经内分泌肿瘤患者淋巴结转移及生存结局的列线图。
J Gastrointest Oncol. 2022 Feb;13(1):171-184. doi: 10.21037/jgo-21-573.
7
Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications.无转移性、手术切除的胰腺神经内分泌肿瘤患者的无复发生存:AJCC 和 ENETS 分期分类的分析。
Ann Surg. 2012 Aug;256(2):321-5. doi: 10.1097/SLA.0b013e31824e6108.
8
Development and validation of a prognostic nomogram for predicting the overall survival of myxofibrosarcoma patients: a large population-based study.预测黏液纤维肉瘤患者总生存期的预后列线图的开发与验证:一项基于大样本人群的研究
Transl Cancer Res. 2021 Feb;10(2):923-937. doi: 10.21037/tcr-20-2588.
9
A prognostic nomogram for the cancer-specific survival of patients with upper-tract urothelial carcinoma based on the Surveillance, Epidemiology, and End Results Database.基于监测、流行病学和最终结果数据库的上尿路上皮癌患者癌症特异性生存的预后列线图。
BMC Cancer. 2020 Jun 8;20(1):534. doi: 10.1186/s12885-020-07019-5.
10
Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.列线图预测Ⅰ期老年小细胞肺癌患者生存的建立与验证。
Bosn J Basic Med Sci. 2021 Oct 1;21(5):632-641. doi: 10.17305/bjbms.2020.5420.

引用本文的文献

1
Comparing the predictive performance of different lymph node staging systems for postoperative overall survival in patients with ampullary carcinoma.比较不同淋巴结分期系统对壶腹癌患者术后总生存的预测性能。
Front Surg. 2023 Feb 27;10:1002411. doi: 10.3389/fsurg.2023.1002411. eCollection 2023.
2
Prognostic Nomogram Based on the Metastatic Lymph Node Ratio for TNM Pancreatic Neuroendocrine Tumors After Surgery.基于手术切除后TNM分期胰腺神经内分泌肿瘤转移淋巴结比率的预后列线图
Front Oncol. 2022 Apr 27;12:899759. doi: 10.3389/fonc.2022.899759. eCollection 2022.
3
Effect of surgical treatment for anorectal melanoma: a propensity score-matched analysis of the Surveillance, Epidemiology, and End Results programme data.

本文引用的文献

1
Lymph node ratio, but not the total number of examined lymph nodes or lymph node metastasis, is a predictor of overall survival for pancreatic neuroendocrine neoplasms after surgical resection.淋巴结比率而非检查的淋巴结总数或淋巴结转移情况,是胰腺神经内分泌肿瘤手术切除后总生存期的一个预测指标。
Oncotarget. 2017 Jul 12;8(51):89245-89255. doi: 10.18632/oncotarget.19184. eCollection 2017 Oct 24.
2
Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas.局限于胰腺及超出胰腺范围的胰腺神经内分泌肿瘤中淋巴结状态及淋巴结清扫范围的预后价值
J Gastrointest Surg. 2016 Dec;20(12):1966-1974. doi: 10.1007/s11605-016-3243-7. Epub 2016 Oct 6.
3
肛门直肠黑色素瘤手术治疗效果的倾向评分匹配分析:监测、流行病学和最终结果计划数据。
BMJ Open. 2022 Apr 21;12(4):e053339. doi: 10.1136/bmjopen-2021-053339.
4
Survival in Patients with Neuroendocrine Tumours of the Small Intestine: Nomogram Validation and Predictors of Survival.小肠神经内分泌肿瘤患者的生存情况:列线图验证及生存预测因素
J Clin Med. 2020 Aug 3;9(8):2502. doi: 10.3390/jcm9082502.
5
Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling.多组学分析评估胰腺高分化神经内分泌肿瘤与导管腺癌的差异。
Int J Mol Sci. 2020 Jun 23;21(12):4470. doi: 10.3390/ijms21124470.
Modified Staging Classification for Pancreatic Neuroendocrine Tumors on the Basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems.
基于美国癌症联合委员会和欧洲神经内分泌肿瘤学会系统的胰腺神经内分泌肿瘤改良分期分类。
J Clin Oncol. 2017 Jan 20;35(3):274-280. doi: 10.1200/JCO.2016.67.8193. Epub 2016 Sep 30.
4
A retrospective cohort study of pancreatic neuroendocrine tumors at single institution over 15 years: New proposal for low- and high-grade groups, validation of a nomogram for prognosis, and novel follow-up strategy for liver metastases.回顾性队列研究:15 年间单中心胰腺神经内分泌肿瘤诊治经验——低级别与高级别分组新建议、预后列线图验证和肝转移随访策略的探索。
Int J Surg. 2016 May;29:108-17. doi: 10.1016/j.ijsu.2016.03.036. Epub 2016 Mar 19.
5
Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter?切除的无功能性胰腺神经内分泌肿瘤的预后:大小和症状有影响吗?
Surgery. 2015 Dec;158(6):1556-63. doi: 10.1016/j.surg.2015.04.035. Epub 2015 Jun 10.
6
The value of serum chromogranin A as a predictor of tumor burden, therapeutic response, and nomogram-based survival in well-moderate nonfunctional pancreatic neuroendocrine tumors with liver metastases.血清嗜铬粒蛋白A在伴有肝转移的中低级别无功能胰腺神经内分泌肿瘤中作为肿瘤负荷、治疗反应及基于列线图的生存预测指标的价值。
Eur J Gastroenterol Hepatol. 2015 May;27(5):527-35. doi: 10.1097/MEG.0000000000000332.
7
Tumor-associated macrophages are a useful biomarker to predict recurrence after surgical resection of nonfunctional pancreatic neuroendocrine tumors.肿瘤相关巨噬细胞是预测无功能胰腺神经内分泌肿瘤手术切除后复发的有用生物标志物。
Ann Surg. 2014 Dec;260(6):1088-94. doi: 10.1097/SLA.0000000000000262.
8
Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival.胰腺神经内分泌肿瘤:影响生存因素的多变量分析
Eur J Surg Oncol. 2014 Nov;40(11):1564-71. doi: 10.1016/j.ejso.2014.06.004. Epub 2014 Jun 30.
9
A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram.单中心 26 年非功能性胰腺神经内分泌肿瘤经验:对现行分期系统的验证和新的预后列线图。
Ann Surg. 2014 Feb;259(2):204-12. doi: 10.1097/SLA.0b013e31828f3174.
10
Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors.一种新型美国癌症联合委员会(AJCC)分期分类系统对胰腺神经内分泌肿瘤预后的有效性。
J Clin Oncol. 2011 Aug 1;29(22):3044-9. doi: 10.1200/JCO.2011.35.1817. Epub 2011 Jun 27.